Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

EMJ Podcast: FLT3 Mutations in Patients with AML

In this episode, we discuss the treatment of patients who have acute myeloid leukemia (AML) as well as FMS-like tyrosine kinase 3 gene (FLT3) mutations.

Pre-transplant Determinants of Outcome in Patients with Myeloma

Multiple myeloma is a malignant neoplasm arising from clonal proliferation of plasma cells in the bone marrow…

New Therapeutic Approaches for Acute Myeloid Leukaemia

Acute myeloid leukaemia (AML) is a life-threatening, multifactorial haematological neoplasm characterised by the accumulation of transformed immature myeloid progenitors…

3D Bone Marrow Model Helps Predict Treatment Response

3D Bone Marrow Model Helps Predict Treatment Response

Predicting individual patient response, as well as progressing understanding of new therapies in development, may be improved by the use of a newly developed 3D bone marrow model.

First Effective Treatment of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

First Effective Treatment of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

Balancing risk of adverse reactions against the protection of effective vaccination is a hotly debated topic in the current phase of the global response to the COVID-19 pandemic. Rare blood clot reactions have been of particular concern, and a recently published case report shares the first successful treatment of a vaccine-induced thrombosis reaction.

The Search for New Therapies for Patients with Myelodysplastic Syndrome: Exploring the Immune and Inflammatory Microenvironments

This symposium took place virtually at the European School of Haematology (ESH) 7th Translational Research e-Conference: Myelodysplastic Syndromes (MDS)…

EMJ Podcast: Emerging Immunotherapies for Patients with Myelodysplastic Syndrome

This episode includes a discussion around myelodysplastic syndrome (MDS). The expert speakers elucidate on data regarding immunotherapy for the treatment of patients living with MDS from the recent European School of Haematology 7th Translational Research Conference.

EMJ Podcast: New Data for the Management of AML

We discuss developments and data presented at the ASH 2020 virtual conference regarding the management of patients with acute myeloid leukaemia (AML).

Loading posts...

« Previous 1 … 64 65 66 67 68 … 100 Next »